Electronic cigarettes for smoking cessation: An overview of systematic reviews and evidence and gap map
Meta-analyses of electronic cigarettes (EC) for smoking cessation report point estimates favouring higher ≥6-month smoking cessation rates with nicotine EC compared with nicotine replacement therapy, non-nicotine EC/placebo, behavioural or no support and mixed support. Evidence on serious adverse events (SAEs) remains inconclusive. Evidence gaps were identified in SAE data and in studies from low- and middle-income countries.
Authors
- Rachna Begh (ORCID: https://orcid.org/0000-0003-0822-9689)
- Caitlin Jade Notley (ORCID: https://orcid.org/0000-0003-0876-3304)
- Annika Theodoulou (ORCID: https://orcid.org/0000-0002-8942-2167)
- Jonathan Livingstone‐Banks (ORCID: https://orcid.org/0000-0002-3757-5591)
- Jamie Hartmann‐Boyce (ORCID: https://orcid.org/0000-0001-9898-3049)
- Angela Difeng Wu (ORCID: https://orcid.org/0000-0001-9726-8975)
- Monserrat Conde
- Eliza Zhitnik
- Ethan Knight
- Peter Hajek
- Tari Turner
- Ailsa R. Butler
- Nicola Lindson
- Hayden McRobbie
Institutions
- University of East Anglia (GB)
- Queen Mary University of London (GB)
- University of Massachusetts Amherst (US)
- UNSW Sydney (AU)
- University of Oxford (GB)
- National Centre for Clinical Research on Emerging Drugs (AU)
- Cochrane (GB)
Publication Details
- Journal
- Addiction
- Published
- 2026-03-26
- DOI
- https://doi.org/10.1111/add.70388
- Primary Topic
- Smoking Behavior and Cessation
- Type
- article
- Field-Weighted Citation Impact
- 0.00